Machine Learning Identifies Vasculogenic Mimicry Risk Model for Medulloblastoma

A research team has constructed and validated a four-gene prognostic risk signature for medulloblastoma based on vasculogenic mimicry, identifying molecular markers that independently predict patient survival outcomes. Medulloblastoma patients categorized into the study’s high-risk group demonstrated significantly worse overall survival compared with those in the low-risk category, yielding a statistically significant difference with a P value of 0.00019. Time-dependent receiver operating characteristic evaluations demonstrated consistent prognostic accuracy across multiple clinical intervals, recording area under the curve metrics of 0.741 at one year, 0.736 at three years, and 0.728 at five years. Subsequent multivariate Cox regression modeling confirmed that the derived risk score functions as an independent prognostic factor, maintaining a hazard ratio greater than one with a corresponding 95 percent confidence interval strictly above one.

The investigation focused on vasculogenic mimicry, a recognized tumor vascularization mechanism operating independently of endothelial cells that researchers have previously associated with increased aggressiveness and unfavorable clinical prognosis across multiple solid tumor types. Despite documented connections in other solid malignancies, the clinical relevance of vasculogenic mimicry within medulloblastoma and its detailed relationship with the broader tumor immune microenvironment had remained largely unexplored.

To establish the foundational genomic cohort, the investigators retrieved the GSE50161 and GSE85217 expression datasets from the public Gene Expression Omnibus database. Differential expression analysis was performed across the genomic data to identify significant transcriptional variations, which were then intersected with established vasculogenic mimicry-related gene sets. The research team subsequently conducted protein-protein interaction network screening across these intersections. This multi-step genomic data processing workflow successfully isolated sixty core vasculogenic mimicry-related differentially expressed genes. Functional pathway profiling indicated that these sixty core genes were significantly enriched in hypoxia processes, epithelial-mesenchymal transition pathways, and a variety of recognized tumor-associated signaling cascades.

Prognostic gene selection proceeded through three computational screening techniques to identify the most robust transcriptional predictors of medulloblastoma survival. The research team implemented univariate Cox regression analysis, least absolute shrinkage and selection operator Cox regression, and random survival forest algorithms across the identified gene sets. Intersecting the candidates selected by all three prognostic screening methods yielded thirteen shared prognostic genes. The authors then performed multivariate Cox regression analysis on these thirteen shared candidates to generate the final prognostic risk model, which condensed the predictive architecture down to a signature consisting of four key genes: MSH6, CASP6, NRP1, and FOXM1.

The performance of the resulting four-gene model was systematically evaluated using Kaplan-Meier survival curves alongside time-dependent receiver operating characteristic curves. In addition to measuring general survival stratification across the entire study population, the researchers carried out dedicated subgroup analyses across established molecular classifications of medulloblastoma. These subgroup evaluations demonstrated that the prognostic risk signature maintained significant prognostic value within both the Sonic Hedgehog and Group 4 molecular subgroups of medulloblastoma.

To explore how the signature aligns with local immunological conditions, the authors evaluated immune cell infiltration across the tumor immune microenvironment using single-sample gene set enrichment analysis. This immune infiltration assessment demonstrated distinct enrichment patterns of infiltrating immune cells when comparing the defined high-risk and low-risk patient groups. Furthermore, the investigators calculated an independent vasculogenic mimicry score to evaluate transcriptional activity and examined its direct correlations with specific immune components. The independent vasculogenic mimicry score displayed statistically significant correlations with multiple immune cell types, showing a prominent positive correlation with natural killer cells at a correlation coefficient of R equals 0.731 and with myeloid-derived suppressor cells at R equals 0.722.

Correlation analyses also examined the direct transcriptional relationship between the specific prognostic markers and the independent vasculogenic mimicry score. The analytical results revealed that all four prognostic genes incorporated into the final risk model—MSH6, CASP6, NRP1, and FOXM1—demonstrated positive correlations with the independent vasculogenic mimicry score. By linking machine learning feature selection, clinical survival data, and immune microenvironment profiling, the study established a verified signature connecting vasculogenic mimicry transcriptional activity with clinical risk assessment in medulloblastoma.

Subject of Research: Prognostic risk signature and immune microenvironment analysis of vasculogenic mimicry in medulloblastoma

Article Title: A vasculogenic mimicry-related prognostic signature for medulloblastoma based on machine learning and immune microenvironment analysis

Article References: Miao, Y., Chen, D., Li, C., Wu, Y., Hong, B., & He, S. (2026). A vasculogenic mimicry-related prognostic signature for medulloblastoma based on machine learning and immune microenvironment analysis. Discover Oncology. https://doi.org/10.1007/s12672-026-06119-1

Image Credits: AI Generated

DOI: 10.1007/s12672-026-06119-1

Keywords: medulloblastoma, vasculogenic mimicry, machine learning, prognostic signature, tumor immune microenvironment, biomarkers, survival analysis, oncology, vasculogenic, mimicry-related, prognostic, signature